EPO Patents = 2

Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Marc Feldmann (4 out of 20 patents)

Jagdeep Nanchahal (4 out of 9 patents)

Glenn R Larsen (4 out of 30 patents)

4 patents: Sort by Forward Citations

1. 12344667 - Method of treating early stage Dupuytren's disease (2025-07-01),

2. 11613570 - Method of treating dupuytren's disease using a pre-filled syringe (2023-03-28),

3. 11400154 - Method of treating a localized fibrotic disorder using an IL-33 antagonist (2022-08-02),

4. 10500273 - Method of treating a localized fibrotic disorder using an IL-33 antagonist (2019-12-10),

180 Therapeutics LP is a biotechnology company focused on developing innovative therapies for metabolic disorders. The company leverages its expertise in drug discovery and development to create novel treatments that address unmet medical needs. With a commitment to excellence and scientific rigor, 180 Therapeutics LP is dedicated to improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#378 in Cambridge, MA

#3,235 in Massachusetts

#59,059 in US

Cambridge, MA, United States of America

180 Therapeutics LP

Forward Citations = 1

3 inventors:

Marc Feldmann (4 out of 20 patents)

Jagdeep Nanchahal (4 out of 9 patents)

Glenn R Larsen (4 out of 30 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com